Histology Impacts the Outcome of Peripheral T-Cell Lymphomas after High Dose Chemotherapy and Stem Cell Transplant

References

• Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der, L., Bron, D., etal. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New England Journal of Medicine, 333, 1540–1545.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84, 1361–1392.
   Google Scholar
• Cheng, AL., Chen, Y.C., Wang, C.H., Su, I.J., Hsieh, H.C., Chang, J.Y., et al. (1989) "Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades — should peripheral T-cell Lymphoma be considered separately?", Journal of Clinical Oncology, 7, 725–731.
   Google Scholar
• Coiffier, B., Brousse, N., Peuchmaur, M., Berger, F., Gisselbrecht, C., Bryon, P.A. and Diebold, J. The GELA (Groupe d'Etude des Lymphomes Agressives) (1990) "Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regi-men", Annals of Oncology, 1, 45–50.
   PubMed Web of Science ®Google Scholar
• Lippman, S.M., Miller, T.P., Spier, C.M., Slymen, D.J. and Grogan, T.M. (1988) "The prognostic significance of the immuno-type in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype", Blood, 72, 436–441.
   Google Scholar
• Gisselbrecht, C., Lepage, E., Molina, T., Quesnel, B., Fillet, G., Lederlin, P., et al. (2002) "Shortened first-line high-dose chemother-apy for patients with poor-prognosis aggressive lymphoma", Journal of Clinical Oncology, 20, 2472— 2479.
   Google Scholar
• Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, B., Younes, A., Andersson, B., et al. (2001) "Impact of high-dose chemotherapy on peripheral T-cell lymphomas", Journal of Clinical Oncology, 19, 3766— 3770.
   PubMed Web of Science ®Google Scholar
• World Health Organization Classification of Tumors (2001) Pathology and Genetics. Tumors of Hematopoietic and Lymphoid Tissues.
   Google Scholar
• Stein, H. (1993) "Ki- 1-anaplastic large cell lymphoma: is it a discrete entity?", Leukemia and Lymphoma, 10, 81— 84.
   PubMedGoogle Scholar
• Kaneko, Y., Frizzera, G., Edamura, S., Maseki, N., Sakurai, M., Komada, Y., et al. (1989) "A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T- cell lymphoma mimicking malignant histiocytosis", Blood, 73, 806–813.
   PubMed Web of Science ®Google Scholar
• Le Beau, M.M., Bitter, M.A., Larson, R.A., Doane, L.A., Ellis, E.D., Franklin, W.A., et al. (1989) "The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1- positive anaplastic large cell lymphoma", Leukemia, 3, 866–870.
   Google Scholar
• Morris, S.W., Kirstein, M.N., Valentine, M.B., Dittmer, K., Shapiro, D.N., Look, A.T. and Saltman, D.L. (1994) "Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma", Science, 263, 1281–1284.
   Google Scholar
• Morris, S.W., Naeve, C., Mathew, P., James, P.L., Kirstein, M.N., Cui, X. and Witte, D.P. (1997) "ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)", Oncogene, 14, 2175 — 2188.
   Web of Science ®Google Scholar
• Pulford, K., Lamant, L., Morris, SM., Butler, L.H., Wood, K.M., Stroud, D., et al. (1997) "Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALKI", Blood, 89, 1394 — 1404.
   Google Scholar
• Stein, H., Foss, H.D., Durkop, H., Marfioti, T., Delsol, G., Pulford, K., et al. (2000) "CD30( +) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features", Blood, 96, 3681 — 3695.
   Google Scholar
• Falini, B., Pileri, S., Zinzani, P.L., Carbone, A., Zagonel, V., Wolf-Peters, C., et al. (1999) "ALK + lymphoma: clinico-pathological findings and outcome", Blood, 93, 2697–2706.
   PubMed Web of Science ®Google Scholar
• Gascoyne, R.D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B.F., Greiner, T.C., et al. (1999) "Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma", Blood, 93, 3913— 3921.
   Google Scholar
• Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the Committee on Hodgkin's Disease Staging Classification", Cancer Research, 31, 1860 — 1861.
   Google Scholar
• Stein, R.S., Greer, J.P., Goodman, S., Brandt, Si., Morgan, D.S., Macon, W.R., et al. (2000) "Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma", Bone Marrow Transplantation, 25, 257–262.
   Google Scholar
• Beylot-Barry, M., Lamant, L., Vergier, B., De Muret, A., Fraitag, S., Delord, B., et al. (1996) "Detection of t(2;5)(p23;q35) transloca-tion by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis", American Journal of Pathology, 149, 483 —492.
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., et al. (1998) "Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)", Blood, 92, 76–82.
   Google Scholar
• Falini, B. (2001) "Anaplastic large cell lymphoma: pathological, molecular and clinical features", British Journal of Haematology, 114, 741 —760.
   PubMed Web of Science ®Google Scholar
• Fanin, R., Ruiz de Elvira, M.C., Sperotto, A., Baccarani, M. and Goldstone, A. (1999) "Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and pediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)", Bone Marrow Transplantation, 23, 437–442.
   Google Scholar
• Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Ciffier, B., Brice, P., et al. (2000) "Survival benefit of high-dose therapy in poor-risk aggressive non- Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol — a groupe d'Etude des lymphomes de l'Adulte study", Journal of Clinical Oncology, 18, 3025–3030.
   Google Scholar
• Mounier, N., Simon, D., Haioun, C., Gaulard, P. and Gisselbrecht, C. (2002) "Impact of high-dose chemotherapy on peripheral T-cell lymphomas", Journal of Clinical Oncology, 20, 1426 — 1427.
   PubMedGoogle Scholar
• Blystad, A.K., Enblad, G., Kvaloy, S., Berglund, A.A., Delabie, J., Holte, H., et al. (2001) "High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas", Bone Marrow Transplantation, 27, 711 —716.
   Google Scholar
• Song, K.W., Mollee, P., Keating, A. and Crump, M. (2002) "Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype", British Journal of Hematology, 120, 978 — 985.
   Web of Science ®Google Scholar
• Vose, J.M., Peterson, C., Bierman, P.J., Weisenburger, D.D., Linder, J., Harrington, D., et al. (1990) "Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas", Blood, 76, 424–431.
   Google Scholar
• Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., et al. (1998) "The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group", Blood, 92, 3562— 3568.
   Google Scholar